AgeneBio, Inc.

AgeneBio, Inc.

AgeneBio, Inc.

Overview
Date Founded

2008

Headquarters

1340 Smith Avenue,Suite 200,Baltimore, MD 21209

Type of Company

Private

Industries

Biotechnology
Holding Companies

Company Description

AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD.

Contact Data
Trying to get in touch with decision makers at AgeneBio, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Director of Business Operations

Media Relations Contact

Board of Directors

Chief Executive Officer at Clarvit Capital

Medical & Scientific Advisor at NeuroVentures Capital LLC

Co-President at Global Health Associates LLC

Senior Vice President at Merck Research Laboratories

Founder at AgeneBio, Inc.

Member, Board of Directors at AgeneBio, Inc.

Paths to AgeneBio, Inc.
Potential Connections via
Relationship Science
You
AgeneBio, Inc.
Recent Transactions
Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Details Hidden

AgeneBio, Inc. raised money in a private placement transaction

Investors
Details Hidden

BioCrossroads focuses on early-stage investments in invests in life sciences opportunities including healthcare informatics, biotechnology manufacturing, agribiotechnology, pharmaceuticals, diagnostics and medical devices. Their objective is to create new jobs and introduce new business opportunities in the state of Indiana.The Indiana Seed Fund I is a seed-stage private investment that provides pre-venture investment capital to emerging, start-up life sciences companies in Indiana. The Fund is a return-driven fund that makes direct equity investments of $50,000 to $500,000.The Indiana Future Fund seek to build an overall investment portfolio with: (1) approximately 60% of its investments placed through Indiana-focused or Indiana-based venture capital funds (2) approximately 70% of its investments made in funds that intend to invest in early-stage or seed-stage companies (3) approximately 60% of its investments are made in Indiana-based companies and (4) approximately 60% of its investments are made in the life sciences sector.

Details Hidden

Founder at AgeneBio, Inc.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by AgeneBio, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of AgeneBio, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and AgeneBio, Inc..